103858-54-4 Usage
General Description
RARECHEM AL BI 0374 is a chemical compound with the CAS number 119505-51-6. It is a rare earth metal compound containing the element bismuth. RARECHEM AL BI 0374 is used in various industrial processes, including as a catalyst in organic synthesis and as a component in the production of electronic and optical materials. It has properties that make it suitable for use in high-tech applications, including its ability to withstand high temperatures and its unique electronic and magnetic properties. Overall, RARECHEM AL BI 0374 is a valuable and versatile chemical compound with a range of industrial uses.
Check Digit Verification of cas no
The CAS Registry Mumber 103858-54-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,8,5 and 8 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 103858-54:
(8*1)+(7*0)+(6*3)+(5*8)+(4*5)+(3*8)+(2*5)+(1*4)=124
124 % 10 = 4
So 103858-54-4 is a valid CAS Registry Number.
103858-54-4Relevant articles and documents
Synthesis and biological evaluation of 2-arylamino-5- (3′-Indolyl)-1,3,4-oxadiazoles as potent cytotoxic agents
Tantak, Mukund P,Kumar, Anil,Noel, Brett,Shah, Kavita,Kumar, Dalip
, p. 1468 - 1474 (2013/09/12)
-
Novel bis(indolyl)hydrazide-hydrazones as potent cytotoxic agents
Kumar, Dalip,Maruthi Kumar,Ghosh, Soumitra,Shah, Kavita
scheme or table, p. 212 - 215 (2012/03/10)
A series of bis(indolyl) hydrazide-hydrazones 5a-n were synthesized and evaluated for their cytotoxicity against selected human cancer cell lines. The reaction of indole-3-carboxaldehyde 2 with indole-3-carbohydrazide 4 in presence of catalytic amount of acetic acid afforded 5a-n in good yields. Among the synthesized bis(indolyl)hydrazide-hydrazones, the compound 5b with N-(p-chlorobenzyl) and bromo substituents was found to be the most potent against multiple cancer cell lines (IC50 = 1.0 μM, MDA-MB-231). The compound 5k exhibited selective cytotoxicity against breast cancer cell line MCF7 (IC50 = 3.1 μM).
